Notes
Reactions Weekly is the complete drug safety alerting service and summarizes information selected from over 1800 biomedical journals. This newsletter is produced by Adis International and is available in a variety of formats. Please contact your nearest Adis office (see inside back cover) for subscription details.
References
Rogers K.C., Wolfe D.A. Amiodarone-induced blue-gray syndrome. Ann Pharmacother 2000 Sep; 34: 1075
Kono T., Ishii M., Taniguchi S. Intranasal buserelin acetate-induced pigmented roseolalike eruption. Br J Dermatol 2000 Sep; 143: 658–659
Chun Y.-S., Chang S.N., Oh D., et al. A case of cutaneous reaction to chemotherapeutic agents showing epidermal dysmaturation. J Am Acad Dermatol 2000 Aug; 43 Suppl. (Pt 2): 358–360
Borgia F., Vaccaro M., Guarneri F., et al. Photodistributed telangiectasia following use of cefotaxime. Br J Dermatol 2000 Sep; 143: 674–675
Möhrenschlager M., Glöckner A., Jessberger B., et al. Codeine caused pruritic scarlatiniform exanthemata: patch test negative but positive to oral provocation test. Br J Dermatol 2000 Sep; 143: 663–664
Marcoux D, Anex R., Russo P. Persistent serpentine supravenous hyperpigmented eruption as an adverse reaction to chemotherapy combining actinomycin and vincristine. J Am Acad Dermatol 2000 Sep; 43: 540–546
Vanhooteghem O., Richert B., Vindevoghel A., et al. Subungual abscess: a new ungual side-effect related to docetaxel therapy. Br J Dermatol 2000 Aug; 143: 462–464
Buckley D.A. Contact allergy to doxepin. Contact Dermatitis 2000 Oct; 43: 231–232
Galaria N.A., Werth V.P., Schumacher H.R. Leukocytoclastic vasculitis due to etanercept. J Rheumatol 2000 Aug; 27: 2041–2044
Skyttä E., Pohjankoski H., Savolainen A. Etanercept and urticaria in patients with juvenile idiopathic arthritis. Clin Exp Rheumatol 2000 Jul–Aug; 18: 533–534
Pemberton M.N., Sloan P., Thakker N.S. Oral lichenoid lesions after hepatitis B vaccination. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontics 2000 Jun; 89: 717–719
Colebunders R., Bottieau E., de Mey I. Curly hair and lipodystrophy as a result of highly active antiretroviral treatment? Arch Dermatol 2000 Aug; 136: 1064–1065
Tsao H., Lerner L.H. Pigmented purpuric eruption associated with injection medroxyprogesterone acetate. J Am Acad Dermatol 2000 Aug; 43(Pt 1): 308–310
Ho N.C., McInerney A., Levy H., et al. Minocycline-induced generalized postinflammatory elastolysis. Am J Med 2000 Sep; 109: 340–341
Dellaripa P.F., Wechsler M.E., Roth M.E., et al. Recurrent panniculitis in a man with asthma receiving treatment with leukotriene-modifying agents. Mayo Clinic Proceedings 2000 Jun; 75: 643–645
Bouldin M.B., Clowers-Webb H.E., Davis J.L., et al. Naproxen-associated linear IgA bullous dermatosis: case report and review. Mayo Clinic Proceed 2000 Sep; 75: 967–970
Cordeiro M.R., Gonçalo M., Fernandes B., et al. Positive lesional patch tests in fixed drug eruptions from nimesulide. Contact Dermatitis 2000 Nov; 43: 307
Goday Buján J.J., Oleaga Morante J.M., González Güemes M., et al. Photoallergic contact dermtitis from piketoprofen. Contact Dermatitis 2000 Nov; 43: 315
Weaver T.D., Jespersen D.L. Multiple onychocryptosis following treatment of onychomycosis with oral terbinafine. Cutis 2000 Sep; 66: 211–212
Yap L.M., Foley P.A., Crouch R.B., et al. Drug-induced solar urticaria due to tetracycline. Australas J Dermatol 2000 Aug; 41: 181–184
Rajkumar S.V., Gertz M.A., Witzig T.E. Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma. N Engl J Med 2000 Sep; 343: 972–973
Rights and permissions
About this article
Cite this article
Cutaneous Drug Reaction Case Reports. Am J Clin Dermatol 2, 49–56 (2001). https://doi.org/10.2165/00128071-200102010-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200102010-00008